huprine x has been researched along with atropine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badia, A; Clos, MV; Roman, S; Vivas, NM | 1 |
| Badia, A; Camps, P; Clos, MV; Muñoz-Torrero, D; Roman, S | 1 |
2 other study(ies) available for huprine x and atropine
| Article | Year |
|---|---|
Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain.
Topics: Acetylcholine; Aminoquinolines; Animals; Atropine; Binding, Competitive; Cerebral Cortex; Cholinesterase Inhibitors; Dopamine; Heterocyclic Compounds, 4 or More Rings; Hippocampus; In Vitro Techniques; Male; Mecamylamine; Muscarinic Antagonists; Nicotinic Antagonists; Pirenzepine; Quinuclidinyl Benzilate; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptors, Muscarinic; Synaptosomes | 2002 |
Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.
Topics: Acetylcholine; Alkaloids; Aminoquinolines; Animals; Atropine; Cholinesterase Inhibitors; Dopamine Antagonists; Dose-Response Relationship, Drug; Galantamine; Haloperidol; Heterocyclic Compounds, 4 or More Rings; In Vitro Techniques; Mecamylamine; Nicotinic Agonists; Nicotinic Antagonists; Parasympatholytics; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Sesquiterpenes | 2005 |